AYALA PHARMACEUTICALS

ayala-pharmaceuticals-logo

Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayalaโ€™s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The com... pany has two product candidates under development, AL101 and AL02, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma, Triple Negative Breast Cancer, T-cell Acute Lymphoblastic Leukemia, Desmoid Tumors and Multiple Myeloma (in collaboration with Novartis).

#SimilarOrganizations #People #Financial #Website #More

AYALA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
2017-01-01

Address:
Wilmington, Delaware, United States

Country:
United States

Website Url:
http://www.ayalapharma.com

Total Employee:
11+

Status:
Active

Contact:
+972-8-373-1541

Email Addresses:
[email protected]

Total Funding:
72 M USD

Technology used in webpage:
Domain Not Resolving Amazon Mobile Non Scaleable Content HSTS Amazon Virginia Region COVID-19 Amazon Route 53 Amazon SSL Akamai Hosted Beaver Builder


Similar Organizations

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

mirum-pharmaceuticals-logo

Mirum Pharmaceuticals

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

phasebio-pharmaceuticals-logo

PhaseBio Pharmaceuticals

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

not_available_image

Principia Pharmaceutical Corporation

Principia Pharmaceutical Corporation has created a revolutionary new way to design and develop oral small molecule therapies.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

regulus-therapeutics-logo

Regulus Therapeutics

Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.

Current Employees Featured

david-caron_image

David Caron
David Caron VP CMC @ Ayala Pharmaceuticals
VP CMC
2018-02-01

roni-mamluk_image

Roni Mamluk
Roni Mamluk CEO & Founder @ Ayala Pharmaceuticals
CEO & Founder
2017-11-01

guy-harmelin_image

Guy Harmelin
Guy Harmelin Founder @ Ayala Pharmaceuticals
Founder

not_available_image

Yonatan Yovell
Yonatan Yovell VP Clinical Development @ Ayala Pharmaceuticals
VP Clinical Development
2022-02-01

andrea-vergara-silva_image

Andrea Vergara-Silva
Andrea Vergara-Silva CMO @ Ayala Pharmaceuticals
CMO
2018-02-01

dana-gelbaum_image

Dana Gelbaum
Dana Gelbaum Chief Business Officer @ Ayala Pharmaceuticals
Chief Business Officer
2020-01-01

not_available_image

Yossi Maimon
Yossi Maimon CFO @ Ayala Pharmaceuticals
CFO
2019-03-01

Founder


guy-harmelin_image

Guy Harmelin

roni-mamluk_image

Roni Mamluk

Stock Details


Company's stock symbol is NASDAQ:AYLA

Acquisitions List

Date Company Article Price
2023-07-27 BioSight BioSight acquired by Ayala Pharmaceuticals N/A
2023-01-19 Advaxis Advaxis acquired by Ayala Pharmaceuticals N/A

Investors List

sio-capital-management_image

Sio Capital Management

Sio Capital Management investment in Post-IPO Equity - Ayala Pharmaceuticals

redmile-group_image

Redmile Group

Redmile Group investment in Post-IPO Equity - Ayala Pharmaceuticals

harel-insurance-investments-and-financial-services_image

Harel Insurance and Financial

Harel Insurance and Financial investment in Series B - Ayala Pharmaceuticals

amoon_image

aMoon Fund

aMoon Fund investment in Series B - Ayala Pharmaceuticals

novartis_image

Novartis

Novartis investment in Series B - Ayala Pharmaceuticals

israel-biotechfund_image

Israel Biotech Fund

Israel Biotech Fund investment in Series B - Ayala Pharmaceuticals

sbi-japan-israel-innovation-fund_image

SBI Japan-Israel Innovation Fund

SBI Japan-Israel Innovation Fund investment in Series B - Ayala Pharmaceuticals

israel-biotechfund_image

Israel Biotech Fund

Israel Biotech Fund investment in Series A - Ayala Pharmaceuticals

Official Site Inspections

http://www.ayalapharma.com

  • Host name: 172.67.139.123
  • IP address: 172.67.139.123
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ayala Pharmaceuticals"

Home - Ayala Pharmaceuticals

AL102 and AL101 were acquired in Q1 2024 by Immunome, Inc.See details»

Ayala Pharmaceuticals - Crunchbase Company Profile โ€ฆ

Contact Email [email protected] Phone Number +972-8-373-1541 Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing โ€ฆSee details»

Ayala Pharmaceuticals Announces Closing of Merger โ€ฆ

Oct 19, 2023 Management and Organization. ... For more information, visit www.ayalapharma.com. Contacts: Ayala Pharmaceuticals: +1-857-444-0553 [email protected]. Story Continues Terms ...See details»

Ayala Pharmaceuticals and Biosight Enter into Definitive Merger โ€ฆ

Jul 27, 2023 Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology asset to Ayalaโ€™s portfolio with data anticipated in the first half of 2024 โ€ฆSee details»

Ayala Pharmaceuticals - Israeli Startup | Startup Nation Finder

Jul 27, 2023 https://ayalapharma.com. Locations. Israel. Prof. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel Offices Abroad. 1007 North Orange Street, Wilmington, DE, USA Photos & โ€ฆSee details»

Ayala Pharmaceuticals (ADXS) Company Profile & Description

6 days ago Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors โ€ฆSee details»

Ayala Pharmaceuticals - LifeScienceHistory.com

Ayalapharma.com. 9 Deer Park Drive, Suite K-1. Monmouth Junction, NJ 08852. Company Info Phone (857) 444-0553 Year Established 2017 Ticker ADXS Exchange OTCQX. Contacts Ken โ€ฆSee details»

Annual Reports - Ayala Pharmaceuticals

1007 North Orange Street, 4th Floor, Wilmington, DE 19801. +1-857-444-0553 . 9 Deer Park Drive, Suite K-1 Monmouth Junction, NJ 08852See details»

Ayala Pharmaceuticals - Craft

Jan 27, 2023 Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined. The company offers AL101 and AL102 โ€ฆSee details»

Ayala Pharmaceuticals Announces Closing of Merger with

Oct 19, 2023 Management and Organization. As previously announced, the combined company will be led by Ayalaโ€™s existing senior management team, with Ken Berlin serving as President โ€ฆSee details»

Ayala Pharmaceuticals - Company Profile & Staff Directory

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and โ€ฆSee details»

Ayala Pharmaceuticals, Inc.

Feb 5, 2025 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement

Merger brings U.S. management and presence, cash to develop compelling late-stage asset. Lead candidate AL102 being evaluated in ongoing Phase 2/3 RINGSIDE study, a potential โ€ฆSee details»

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to โ€ฆ

Mar 26, 2024 For more information, visit www.ayalapharma.com. Cautionary Statement Regarding Forward-Looking Statements The statement contained in this release that Ayala โ€ฆSee details»

Ayala Pharmaceuticals - Overview, News & Similar companies

Ayala Pharmaceuticals contact info: Phone number: +972 83731541 Website: www.ayalapharma.com What does Ayala Pharmaceuticals do? Ayala Pharmaceuticals, Inc., a โ€ฆSee details»

Ayala Pharmaceuticals Company Profile | Management and

Www.ayalapharma.com Ayala Pharmaceuticals Profile and History Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule โ€ฆSee details»

Ayala Pharmaceuticals and Biosight Enter into Definitive

Jul 27, 2023 Management and Organization. ... For more information, visit www.ayalapharma.com. About AL102. AL102 is an investigational small molecule gamma โ€ฆSee details»

Ayala Pharmaceuticals Company Overview, Contact Details

Feb 19, 2021 This presents a potential sales opportunity for companies looking to be acquired by a growing oncology-focused organization. ... Jul 05, 2023 | ayalapharma.gcs-web.com. โ€ฆSee details»

Philippinesโ€™ Ayala Corp. Aims To Quadruple AC Healthโ€™s ... - Forbes

1 hour ago Ayala Corp. president and CEO Bong Consing said the conglomerate has poured about 15 billion pesos into AC Health since it started in 2015, and has expanded rapidly in the โ€ฆSee details»

News Releases - Ayala Pharmaceuticals

Feb 6, 2024 MONMOUTH JUNCTION, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced โ€ฆSee details»

linkstock.net © 2022. All rights reserved